🔍 精确匹配标题和内容
重置
Nature
8.0
0
Bioinformatic analysis of rare endothelial protein C receptor missense variants associated with coagulation and thrombophilia risk

本研究利用生物信息学方法分析了PROCR基因中的稀有错义突变,揭示了这些突变与凝血和血栓形成风险的关联。研究表明,特定突变可能通过影响蛋白质功能和相互作用来增加血栓风险,强调了PROCR在血液凝固调节中的重要角色。这些发现为个性化风险评估和未来的治疗策略提供了基础,具有重要的临床应用潜力。

2025-10-22 00:02 website
Nature
8.5
0
Machine learning improves detection of alpha thalassemia carriers compared to clinical features

本研究开发了一种基于机器学习的模型,以提高α-地中海贫血携带者的检测准确性。通过分析956个病例的血液参数,研究表明,采用堆叠集成模型可达到94%的准确率,且关键预测因子包括红细胞计数和血红蛋白水平。该研究强调了机器学习在血液疾病诊断中的潜力,尤其是在高发地区如东南亚和伊朗,提供了更为个性化的筛查方法。

2025-10-22 00:01 website
Nature
8.0
0
Visual outcomes and anatomical biomarkers of Faricimab for diabetic macular edema in the J-CREST real-world comparison of naïve and treated eyes

本研究评估了Faricimab在糖尿病性黄斑水肿(DME)患者中的真实世界疗效,涉及174名患者。结果显示,Faricimab在改善视觉和视网膜解剖结果方面表现出显著效果,尤其是在未接受过治疗的患者中。研究发现,早期的内核层水肿和视网膜下液的消退与视觉预后显著相关,强调了个体化治疗策略的重要性。

2025-10-21 23:58 website
Nature
8.0
0
Integration of single-cell and bulk RNA sequencing data to identify liquid–liquid phase separation-related prognostic biomarkers in hepatocellular carcinoma

本研究整合了单细胞和大规模RNA测序数据,识别了与肝细胞癌相关的液-液相分离生物标志物,并开发了预后模型。研究结果显示,液-液相分离在肝细胞癌的进展中起着关键作用,提供了潜在的治疗靶点。

2025-10-21 23:57 website
Nature
8.0
0
Disrupting mitochondrial β-oxidation by depletion of HADHA impairs primary ciliogenesis

本研究探讨了HADHA在初级纤毛形成中的关键作用,发现HADHA缺失导致初级纤毛的形成和信号传导受损。研究表明,补充醋酸盐可以恢复HADHA缺失细胞的初级纤毛功能,提示其在HADHA相关疾病的治疗中具有潜在的应用价值。此外,HADHA E510Q突变与多种临床表现相关,强调了其在疾病机制中的重要性。

2025-10-21 23:55 website
Nature
8.0
0
Reverse vaccinology-driven construction and bioinformatics validation of a multi-epitope vaccine against Brucella spp.

The study focuses on the development of a multi-epitope vaccine (MEV) against Brucella spp. using reverse vaccinology and bioinformatics. The MEV targets specific membrane proteins and has shown high antigenicity, non-toxicity, and good solubility. The research highlights the urgent need for effective vaccines against brucellosis, a significant zoonotic disease affecting both human health and livestock. Future in vivo experiments are planned to validate the vaccine's efficacy and safety.

2025-10-21 23:53 website
Nature
8.4
0
Bioinformatics analyses of comorbid mechanisms between psoriasis and type 2 diabetes mellitus

This study employs bioinformatics to analyze the comorbid mechanisms between psoriasis and type 2 diabetes mellitus (T2DM). It identifies 71 co-differentially expressed genes (co-DEGs) and highlights four crucial co-driver genes (BEX5, EPHX2, GPRASP1, RBP4) with significant diagnostic potential. The research reveals shared immune-inflammatory pathways, suggesting a common pathophysiology that warrants further investigation. The findings may inform future therapeutic strategies for managing these interconnected conditions.

2025-10-21 23:52 website
Nature
8.0
0
Safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies in healthy adults: a phase 1 trial

本研究为一项I期临床试验,评估了合成DNA编码单克隆抗体(DMAb)在健康成人中的安全性和药代动力学。研究结果显示,DMAb在所有参与者中均可持续表达,并对多种SARS-CoV-2变异株具有中和活性。该技术提供了一种新的抗体递送平台,具有长效性和冷链独立性,且未检测到抗药物抗体,显示出良好的免疫耐受性。这些发现为抗体基因递送的未来研究奠定了基础。

2025-10-21 23:52 website
Nature
8.0
0
PARP inhibitor and PRMT5 inhibitor synergy is independent of BRCA1/2 and MTAP status in breast cancer cells

本研究探讨了PRMT5抑制剂与PARP抑制剂在乳腺癌细胞中的协同作用,发现该组合在BRCA1/2野生型细胞系中表现出更高的协同效应。研究结果表明,PRMT5抑制剂能够增强PARP抑制剂的抗肿瘤效果,尤其是在缺乏BRCA1/2突变的乳腺癌患者中,具有重要的临床应用潜力。

2025-10-21 23:52 website
Nature
8.0
0
Crocetin curbs radiation induced intestinal injury by blocking KAT2A/NLRP3 succinylation

Crocetin, a natural compound, has been shown to protect against radiation-induced intestinal injury by inhibiting KAT2A-mediated succinylation of NLRP3. This study provides evidence that crocetin enhances intestinal cell viability and reduces pyroptosis in irradiated models, suggesting its potential as a therapeutic agent in oncology, particularly for mitigating side effects of radiotherapy.

2025-10-21 23:51 website
Nature
8.5
0
Osthol ameliorates obesity-associated lipid metabolic disorders by inhibiting ADRA1D-dependent Th17 cell differentiation

Osthol (OST) is shown to ameliorate obesity-related metabolic disorders by inhibiting Th17 cell differentiation through ADRA1D signaling. In HFD-induced obesity models, OST reduced body weight, serum lipids, and liver damage, while enhancing anti-inflammatory cytokines. The study provides insights into OST's mechanism, suggesting its potential as a therapeutic target for metabolic diseases, emphasizing the importance of ADRA1D in regulating inflammation and lipid metabolism.

2025-10-21 23:51 website
Nature
9.0
0
Identification of a novel m6A RNA methylation regulator-based signature for prognosis and immune landscape prediction in hepatocellular carcinoma

本研究开发了一种基于N6-甲基腺苷(m6A) RNA甲基化调节因子的预后模型(m6A-RPS),用于肝细胞癌(HCC)的预后预测和免疫微环境评估。通过对TCGA、GEO和ICGC数据库的综合生物信息学分析,发现m6A调节因子在HCC组织中广泛失调,并与患者的生存期和临床特征显著相关。该模型不仅能够有效区分高风险和低风险患者,还为个性化治疗策略提供了重要的指导,尤其是在免疫治疗选择方面,显示出良好的临床应用潜力。

2025-10-21 23:51 website
Nature
8.4
0
Integrative transcriptomic analysis identifies shared EndMT-related gene signatures in endometriosis and recurrent miscarriage

本研究通过整合转录组分析,探讨了内皮-间质转化(EndMT)在子宫内膜异位症和复发性流产中的作用,识别了13个共享的EndMT相关基因。这些基因在两个疾病中均表现出显著的表达差异,且具有良好的诊断性能。研究结果强调了EndMT在这两种疾病的共同发病机制中的重要性,并为未来的临床干预提供了潜在的靶点。

2025-10-21 23:51 website
Nature
8.5
0
Deubiquitinating enzyme USP42 promotes breast cancer progression by inhibiting JNK/p38-mediated apoptosis

USP42, a deubiquitinating enzyme, plays a critical role in breast cancer progression by inhibiting apoptosis through the JNK/p38 signaling pathway. The study demonstrates that higher levels of USP42 correlate with advanced cancer stages and poor prognosis. Knockdown of USP42 in breast cancer cell lines led to reduced cell proliferation and increased apoptosis, indicating its potential as a therapeutic target. These findings underscore the importance of USP42 in breast cancer biology and highlight the need for further investigation into its mechanisms.

2025-10-21 23:51 website
Nature
8.0
0
Single-cell and bulk transcriptomics uncovers PRKD2-driven tumor stemness and progression in multiple myeloma

本研究揭示了PRKD2在多发性骨髓瘤中的关键作用,显示其在疾病进展、免疫逃逸及治疗反应中的重要性。PRKD2的表达与患者预后密切相关,且其高表达与对Axitinib的敏感性增加相关,提示PRKD2可能成为新的治疗靶点。研究结果为多发性骨髓瘤的精准治疗提供了新的思路,强调了针对PRKD2的药物开发的必要性。

2025-10-21 23:50 website
第 137 页,共 287 页 (显示 15 篇文章)